Abstract:Abstract Background: Forkhead box protein H1 (FOXH1) is upregulated in a variety of cancer types but its expression patterns and specific functions in lung cancer are unclear at present. The main objective of the present study was to establish whether FOXH1 plays a role in regulation of lung cancer progression. Methods: The TCGA and Kaplan-Meier plotter dataset was analyzed for possible association between FOXH1 expressions in lung cancer tissues and patient prognosis. A549 and PC9 cells were transfected with shRNA targeting FOXH1 mRNA. The Cell Counting Kit-8 (CCK8), plate clone formation, soft agar, wound healing, transwell invasion and flow cytometry assay were performed to detect the cell proliferation, migration and invasion in lung cancer cells. Tumorigenicity was examined in mouse model system. Western blot analysis was used to detect FOXH1, Matrix metalloproteinase 2 (MMP2), Vimentin, N-cadherin, E-cadherin, Snail, Slug, p-GSK-3β, β-catenin and Cyclin D1. The β-catenin activity was measured by luciferase reporter system assay. Results: FOXH1 expression in the lung cancer was determined using the TCGA and Kaplan-Meier plotter databases. Higher expression of FOXH1 was observed in tumor tissue relative to normal tissue, which was associated with reduced overall survival. FOXH1 knockdown resulted in significant inhibition of the proliferation, the cell cycle, the migration as well as the invasion of lung cancer cells. Then, we confirmed that FOXH1 knockdown can significantly slow down tumor growth and tumor cell proliferation in vivo using the mouse model. It also significantly reduced the migration and invasion capabilities of lung cancer cells. Using Western blot analyses, we found that FOXH1 depletion inhibited the epithelial-mesenchymal transition of lung cancer cells through downregulation of the mesenchymal cell markers Snail, Slug, MMP2, N-cadherin, and Vimentin, and upregulation of the epithelial marker E-cadherin. Moreover, FOXH1 knockdown significantly downregulated β-catenin and its downstream targets, such as p-GSK-3β and cyclin D1, and also led to direct suppression of β-catenin activity, as determined by the luciferase reporter system assay. Conclusion: In conclusion, FOXH1 promotes proliferation, migration, and invasion of lung cancer cells via regulation of Wnt/β-catenin signaling. FOXH1 is a prognostic marker and a potential therapeutic target for lung cancer treatment.

HSPA12B: a novel facilitator of lung tumor growth.

Heat Shock Protein 27 Promotes Cell Proliferation Through Activator Protein-1 in Lung Cancer.

Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth

Downregulation of HSPA2 Inhibits Proliferation Via ERK1/2 Pathway and Endoplasmic Reticular Stress in Lung Adenocarcinoma

Heat Shock Protein A12A Activates Migration of Hepatocellular Carcinoma Cells in a Monocarboxylate Transporter 4–dependent Manner

Extracellular HSPA1A Promotes the Growth of Hepatocarcinoma by Augmenting Tumor Cell Proliferation and Apoptosis-Resistance

HSPA12A Stimulates P38/erk-Ap-1 Signaling to Promote Angiogenesis and is Required for Functional Recovery Postmyocardial Infarction.

Heat Shock Protein B6 Potently Increases Non-Small Cell Lung Cancer Growth.

PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer

HSPE1 Enhances Aerobic Glycolysis to Promote Progression of Lung Adenocarcinoma

TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment

Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma

Expression of Hedgehog Signaling Molecules in Lung Cancer.

HSPA12A stimulates "Smurf1-Hif1α-aerobic glycolysis" axis to promote proliferation of renal tubular epithelial cells after hypoxia/reoxygenation injury

HAX1enhances the survival and metastasis of non-small cell lung cancer through theAKT/mTORandMDM2/p53 signaling pathway

FOXH1 Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer

HSPA12A was identified as a key driver in colorectal cancer GWAS loci 10q26.12 and modulated by an enhancer-promoter interaction

Effects of Tumor-Associated Mitochondrial Protein 12 on Tumor Cell Growth in Xenograft Mice

FOXH1&nbsp;Promotes Tumor Growth and Metastasis via Regulation of Wnt/β-catenin Signaling Pathway in Lung Cancer&nbsp;

HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.

ANGPTL2/LILRB2 Signaling Promotes the Propagation of Lung Cancer Cells